Management of anterior chamber dislocation of a dexamethasone intravitreal implant: A case report

被引:0
|
作者
Pacella F. [1 ]
Agostinelli E. [2 ]
Carlesimo S.C. [1 ]
Nebbioso M. [1 ]
Secondi R. [1 ]
Forastiere M. [1 ]
Pacella E. [1 ]
机构
[1] Department of Sense Organs, Faculty of Medicine and Dentistry, Sapienza University of Rome, Viale del Policlinico, Rome
[2] Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome
关键词
Case report; Cystoid macular edema; Intravitreal dexamethasone implant; Ozurdex; Ozurdex dislocation;
D O I
10.1186/s13256-016-1077-2
中图分类号
学科分类号
摘要
Background: Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon complication of the intravitreal injection, which can be managed by repositioning the implant into the vitreous cavity. We describe the case of a successful repositioning of an Ozurdex implant by mobilization and subsequent balanced saline solution injection in the anterior chamber. Case presentation: An 83-year-old white woman presented to our Emergency Unit complaining of pain and vision loss in herright eye lasting a week. Her anamnesis revealed a history of persistent cystoid macular edema after phacoemulsification with scleral-fixated posterior chamber intraocular lens implantation, recently treated with an intravitreal Ozurdex implant. She also took a long-distance flight 2 days after the injection. An anterior segment examination showed corneal edema and the rod implant adherent to corneal endothelium. To avoid corneal decompensation, we opted for a implant repositioning. Under topical anesthesia, a 30-gauge needle was introduced through a limbar incisionto mobilize the dislocated rod. Balanced saline solution was injected, with a successful repositioning of the implant into the vitreous cavity. Topical 5 % hypertonic saline solution and 0.2 % betamethasone associated with 0.5 % chloramphenicol drops were administered four times a day. To prevent redislocation of the Ozurdex implant, she was instructed to avoid prone position, any kind of physical effort, and not to undertake long-distance flights during the first postoperative week. One week after surgery, an anterior segment examination showed an improvement of corneal edema. Funduscopy showed that the Ozurdex implant was settled into the vitreous cavity. Conclusions: Anterior chamber dislocation of Ozurdex from the vitreous cavity is rare. In our patient, in addition to the posterior capsule tearing, the long-distance flight could have contributed to implant dislocation. Repositioning of the implant is necessary to avoid endothelial decompensation. It can be carried out by using saline balanced solution with the same efficacy as other surgical procedures reported in the literature. A possible disadvantage of this procedure could be implant migration. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [31] Migration of a Fluocinolone Acetonide Intravitreal Implant Into the Anterior Chamber
    Li, Angela S.
    Nguyen, Huy V.
    Do, Diana V.
    JAMA OPHTHALMOLOGY, 2020, 138 (10)
  • [32] Anterior chamber migration of dexametasone intravitreal implant (OzurdexA®)
    Pardo-Lopez, Diamar
    Frances-Munoz, Ester
    Gallego-Pinazo, Roberto
    Diaz-Llopis, Manuel
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (11) : 1703 - 1704
  • [33] Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®)
    Diamar Pardo-López
    Ester Francés-Muñoz
    Roberto Gallego-Pinazo
    Manuel Díaz-Llopis
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2012, 250 : 1703 - 1704
  • [34] Dexamethasone Implant Anterior Chamber Migration Risk Factors, Complications, and Management Strategies
    Khurana, Rahul N.
    Appa, Suri N.
    McCannel, Colin A.
    Elman, Michael J.
    Wittenberg, Susan E.
    Parks, David J.
    Ahmad, Saad
    Yeh, Steven
    OPHTHALMOLOGY, 2014, 121 (01) : 67 - 71
  • [35] The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®)
    Hyunseung Kang
    Min Woo Lee
    Suk Ho Byeon
    Hyoung Jun Koh
    Sung Chul Lee
    Min Kim
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 1819 - 1825
  • [36] The Clinical Outcomes of Surgical Management of Anterior Chamber Migration of a Dexamethasone Implant (Ozurdex®)
    Kang, Hyunseung Ashlee
    Lee, Min Woo
    Byeon, Suk Ho
    Koh, Hyoung Jun
    Lee, Sung Chul
    Kim, Sung Soo
    Kim, Min
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [37] Spontaneous Dislocation of a Transparent Lens to the Anterior Chamber - A Case Report
    Jovanovic, Milos
    Stefanovic, Ivan
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2010, 138 (7-8) : 486 - 488
  • [39] Treatment of Experimental Anterior and Intermediate Uveitis by a Dexamethasone Intravitreal Implant
    Ghosn, Corine R.
    Li, Yong
    Orilla, Werhner C.
    Lin, Ton
    Wheeler, Larry
    Burke, James A.
    Robinson, Michael R.
    Whitcup, Scott M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (06) : 2917 - 2923
  • [40] Management of Accidental Intravitreal Dexamethasone Injection Into the Lens: A Case Report
    Pintor, Emanuele Siotto
    Demarinis, Giuseppe
    Tatti, Filippo
    Peiretti, Enrico
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)